Daniel Loeb - Third Point
Holding/activity history for Ligand Pharmaceuticals Inc. (LGND)
← All LGND superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2011 Q4 | 0 | 0.00 | Sell 100.00% | 0.54 | $6.55–9.93 · VW $8.14i | SEC | |
| 2011 Q3 | 1,130,141 | 0.54 | $8.53 | $9,645,000 | SEC | ||
| 2011 Q2 | 1,130,141 | 0.44 | Add 110.73% | 0.23 | $5.86–7.52 · VW $6.82i | $8,425,000 | SEC |
| 2011 Q1 | 536,296 | 0.22 | Reduce 0.00% | $5.39–6.92 · VW $6.09i | $3,346,000 | SEC | |
| 2010 Q4 | 536,298 | 0.24 | Buy | 0.24 | $5.08–9.23 · VW $5.96i | $2,984,000 | SEC |
Price snapshot:
Current price$309.25
52-week low$120.68
52-week high$326.63